Therefore, given the prevalence of anaemia and its impact on the quality of life in IBD, we studied prohepcidin levels and iron homeostasis and their potential modifications induced by anti-TNF treatment in a group of patients with IBD. The gene discussed is TNF; the disease is inflammatory bowel disease.